Chosa Oncology AB Statistics
Total Valuation
FRA:W5L has a market cap or net worth of EUR 3.58 million. The enterprise value is 3.35 million.
Important Dates
The next estimated earnings date is Tuesday, November 24, 2026.
| Earnings Date | Nov 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FRA:W5L has 91.44 million shares outstanding. The number of shares has increased by 23.85% in one year.
| Current Share Class | 91.44M |
| Shares Outstanding | 91.44M |
| Shares Change (YoY) | +23.85% |
| Shares Change (QoQ) | -1.37% |
| Owned by Insiders (%) | 8.18% |
| Owned by Institutions (%) | 9.01% |
| Float | 56.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.75 |
| P/TBV Ratio | 3.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.06, with zero debt.
| Current Ratio | 2.06 |
| Quick Ratio | 2.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -37.75% and return on invested capital (ROIC) is -27.55%.
| Return on Equity (ROE) | -37.75% |
| Return on Assets (ROA) | -24.67% |
| Return on Invested Capital (ROIC) | -27.55% |
| Return on Capital Employed (ROCE) | -38.73% |
| Weighted Average Cost of Capital (WACC) | 13.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -91,576 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.50% in the last 52 weeks. The beta is 1.65, so FRA:W5L's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -62.50% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 45.89 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -668,395 |
| Pretax Income | -663,879 |
| Net Income | -572,303 |
| EBITDA | -600,411 |
| EBIT | -668,395 |
| Earnings Per Share (EPS) | -0.01 |
Full Income Statement Balance Sheet
The company has 231,197 in cash and no debt, with a net cash position of 231,197 or 0.00 per share.
| Cash & Cash Equivalents | 231,197 |
| Total Debt | n/a |
| Net Cash | 231,197 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.73M |
| Book Value Per Share | 0.02 |
| Working Capital | 187,757 |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -505,995 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 67,499 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:W5L does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -23.85% |
| Shareholder Yield | -23.85% |
| Earnings Yield | -19.74% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |